p21 and p27 immunoexpression in gastric well differentiated endocrine tumors (ECL-cell carcinoids)

World Journal of Gastroenterology

Volumn 12, Issue 39, 2006, Pages 6280-6284

  Doganavsargil, Basak ^a   Sarsik, Banu ^a   Kirdok, Fatma Secil ^a   Musoglu, Ahmet ^a   Tuncyurek, Muge ^a  

^a EGE UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

Author keywords

Cyclin dependent kinase inhibitors; Gastrointestinal carcinoids; p21waf1; p27kip1; Stomach; Well differentiated endocrine tumors

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 1; CYCLIN DEPENDENT KINASE INHIBITOR 1B; KI 67 ANTIGEN;

ADULT; AGE; AGED; ARTICLE; ATROPHIC GASTRITIS; CANCER DIAGNOSIS; CANCER LOCALIZATION; CANCER PATIENT; CELL HYPERPLASIA; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DYSPLASIA; ENDOSCOPIC BIOPSY; FEMALE; GENDER; HUMAN; IMMUNOHISTOCHEMISTRY; INTESTINE METAPLASIA; MALE; MITOSIS INDEX; MULTIPLE CANCER; NEUROENDOCRINE DISEASE; NEUROSECRETORY CELL; OUTCOME ASSESSMENT; PROTEIN EXPRESSION; SCORING SYSTEM; STOMACH CARCINOID; STOMACH FUNDUS; STOMACH MUCOSA; SUBMUCOSA; TUMOR DIFFERENTIATION;

EID: 33750843747     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v12.i39.6280     Document Type: Article

References (23)

1. Maggard MA, O'Connell JB, Ko CY. Updated population-based review of carcinoid tumors. Ann Surg 2004; 240:117-122
2. Fenoglio-Preiser CM. Gastrointestinal pathology plus: An atlas and text. CD-ROM version. Hagerstown: Lippincott Williams & Wilkins Publishers, 1999
3. Hegde V, Mohandas KM, Ramadwar M, Shukla P, Mehta S. Gastric carcinoids--a changing trend. Indian J Gastroenterol 2003; 22: 209-211
4. Modlin IM, Lye KD, Kidd M. Carcinoid tumors of the stomach. Surg Oncol 2003; 12:153-172
5. Modlin IM, Lye KD, Kidd M. A 50-year analysis of 562 gastric carcinoids: small tumor or larger problem? Am J Gastroenterol 2004; 99: 23-32
6. Solcia E, Klöppel G, Sabin LH, eds. Histological typing of endocrine tumours. WHO International Histological Classification of Tumours. 2nd ed. Berlin- Springer, 2000: 61-68
7. Hamilton SR, Aaltonen LA. Pathology and genetics of tumours of the digestive system. World Health Organisation Classification of Tumours. Lyon: IARC Press; 2000: 53-54
8. Modlin IM, Kidd M, Lye KD. Biology and management of gastric carcinoid tumours: a review. Eur J Surg 2002; 168: 669-683
9. Xie SD, Wang LB, Song XY, Pan T. Minute gastric carcinoid tumor with regional lymph node metastasis: a case report and review of literature. World J Gastroenterol 2004; 10: 2461-2463
10. Shinohara T, Ohyama S, Nagano H, Amaoka N, Ohta K, Matsubara T, Yamaguchi T, Yanagisawa A, Kato Y, Muto T. Minute gastric carcinoid tumor with regional lymph node metastasis. Gastric Cancer 2003; 6:262-266
11. Lloyd RV, Erickson LA, Jin L, Kulig E. Qian X, Cheville JC, Scheithauer BW. p27kip1: a multifunctional cyclin-dependent kinase inhibitor with prognostic significance in human cancers. Am J Pathol 1999; 154: 313-323
12. Erickson LA, Jin L, Wollan P, Thompson GB, van Heerden JA, Lloyd RV. Parathyroid hyperplasia, adenomas, and carcinomas: differential expression of p27Kip1 protein. Am J Surg Pathol 1999; 23:288-295
13. Cheng L, Lloyd RV, Weaver AL, Pisansky TM, Cheville JC, Ramnani DM, Leibovich BC, Blute ML, Zincke H, Bostwick DG. The cell cycle inhibitors p21WAF1 and p27KIP1 are associated with survival in patients treated by salvage prostatectomy after radiation therapy. Clin Cancer Res 2000; 6: 1896-1899
14. Matsushima H, Sasaki T, Goto T, Hosaka Y, Homma Y, Kitamura, T, Kawabe K, Sakamoto A, Murakami T, Machinami R. Immunohistochemical study of p21WAF1 and p53 proteins in prostatic cancer and their prognostic significance. Hum Pathol 1998; 29: 778-783
15. Canavese G, Azzoni C, Pizzi S, Corleto VD, Pasquali C, Davoli C, Crafa P, Delle Fave G, Bordi C. p27: a potential main inhibitor of cell proliferation in digestive endocrine tumors but not a marker of benign behavior. Hum Pathol 2001; 32: 1094-1101
16. Kawahara M, Kammon M, Kanauchi H, Noguchi C, Kuramoto S, Kaminishi M, Endo H, Takubo K. Immunohistochemical prognostic indicators of gastrointestinal carcinoid tumours. Eur J Surg Oncol 2002; 28: 140-146
17. Ahlman H, Kolby L, Lundell L, Olbe L, Wangberg B, Granerus G, Grimelius L, Nilsson 0. Clinical management of gastric carcinoid tumors. Digestion 1994; 55 Suppl 3: 77-85
18. Polyak K, Lee MH, Erdjument-Bromage H, Koff A, Roberts JM, Tempst P, Massague J. Cloning of p27Kip1, a cyclindependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals. Cell 1994; 78: 59-66
19. Zirbes TK, Lorenzen J, Baldus SE, Moenig SP, Wolters U, Ottlik A, Thiele J, Holscher AH, Dienes HP. Apoptosis and expression of bcl-2 protein are inverse factors influencing tumour cell turnover in primary carcinoid turnours of the lung. Histopathology 1998; 33:123-128
20. Philipp-Staheli J, Kim KH, Liggitt D, Gurley KE, Longton G, Kemp CJ. Distinct roles for p53, p27Kip1, and p21Cip1 during tumor development. Oncogene 2004; 23:905-913
21. McKay JA, Douglas JJ, Ross VG, Curran S, Loane JF, Ahmed FY, Cassidy J, McLeod HL, Murray GI. Analysis of key cell-cycle checkpoint proteins in colorectal tumours. J Pathol 2002; 196:386-393
22. Haitel A, Wiener HG, Neudert B, Marberger M, Susani M. Expression of the cell cycle proteins p21, p27, and pRb in clear cell renal cell carcinoma and their prognostic significance. Urology 2001; 58:477-481
23. Lloyd RV, Jin L, Qian X, Kulig E. Aberrant p27kip1 expression in endocrine and other tumors. Am J Pathol 1997; 150:401-407